Leaderboards/Cancer Genomics and Diagnostics

Cancer Genomics and Diagnostics

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Yuhan Hao
Jilin University
2
Jaime A. Castro-Mondragón
Inserm
3
Ieva Rauluševičiūtė
University of Oslo
4
Zachary Sethna
Memorial Sloan Kettering Cancer Center
5
Aleksandr Ianevski
Institute for Molecular Medicine Finland
6
Alessandro Mannucci
Vita-Salute San Raffaele University
7
Marcos Díaz‐Gay
University of California San Diego
8
Xupeng Yang
Ministry of Education
9
Avishai Gavish
Howard Hughes Medical Institute
10
Jinxi Xiang
Stanford University

Papers

1
Precision treatment in advanced hepatocellular carcinoma
Cancer Cell|2024
393 cit.
2
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
Nature|2025
232 cit.
3
Publication in Nature (2025) [169 citations, W4406168947]
Nature|2025
169 cit.
4
Geographic and age variations in mutational processes in colorectal cancer
Nature|2025
123 cit.
5
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones
Nature Communications|2024
50 cit.
6
The mutagenic forces shaping the genomes of lung cancer in never smokers
Nature|2025
37 cit.
7
The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants
Antiviral Research|2024
23 cit.
8
RepurposeDrugs: an interactive web-portal and predictive platform for repurposing mono- and combination therapies
Briefings in Bioinformatics|2024
20 cit.
9
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future
CA A Cancer Journal for Clinicians|2025
15 cit.
10
Study of photocatalytic degradation of dyeing wastewater with CdS nanoparticles anchored on cotton short staple-based carbon aerogels
Journal of Alloys and Compounds|2024
10 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Martin L. Ferguson
National Cancer Institute
2
Adam Abeshouse
Memorial Sloan Kettering Cancer Center
3
Anthony Mathelier
Oslo University Hospital
4
Ina Felau
National Cancer Institute
5
Moriah G. Nissan
Van Andel Institute
6
Peter J. Campbell
Wellcome Sanger Institute
7
Leonid Kvecher
Windber Research Institute
8
Ruben van Boxtel
Oncode Institute
9
Lincoln D. Stein
Ontario Institute for Cancer Research
10
Tingting Zhao
Tongji University

Papers

1
JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles
Nucleic Acids Research|2023
1k cit.
2
MutationalPatterns: the one stop shop for the analysis of mutational processes
BMC Genomics|2022
181 cit.
3
Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer
Cancer Cell|2024
89 cit.
4
JASPAR 2026: expansion of transcription factor binding profiles and integration of deep learning models
Nucleic Acids Research|2025
49 cit.
5
Pioneer transcription factors are associated with the modulation of DNA methylation patterns across cancers
Epigenetics & Chromatin|2022
40 cit.
6
Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms
Cancer Discovery|2022
33 cit.
7
Comprehensive single-cell genome analysis at nucleotide resolution using the PTA Analysis Toolbox
Cell Genomics|2023
16 cit.
8
Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms
Nature Communications|2024
16 cit.
9
Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers
Nucleic Acids Research|2022
11 cit.
10
Human induced pluripotent stem cells display a similar mutation burden as embryonic pluripotent cells in vivo
iScience|2022
9 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Bert Vogelstein
Johns Hopkins University
2
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
3
Ahmedin Jemal
American Cancer Society
4
Gad Getz
Broad Institute
5
Michael R. Stratton
Wellcome Sanger Institute
6
Heidi L. Rehm
Unknown
7
Kenneth W. Kinzler
Johns Hopkins University
8
Matthew Meyerson
Broad Institute
9
Peter J. Campbell
Wellcome Sanger Institute
10
Victor E. Velculescu
Johns Hopkins University

Papers

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2018
87.7k cit.
2
Global cancer statistics
CA A Cancer Journal for Clinicians|2011
55k cit.
3
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Genetics in Medicine|2015
32.2k cit.
4
Global cancer statistics, 2012
CA A Cancer Journal for Clinicians|2015
27.4k cit.
5
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Analytical Biochemistry|1983
25.2k cit.
6
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2024
23.1k cit.
7
Cancer statistics, 2020
CA A Cancer Journal for Clinicians|2020
21.4k cit.
8
Cancer statistics, 2019
CA A Cancer Journal for Clinicians|2019
21k cit.
9
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Cancer Discovery|2012
18.4k cit.
10
Cancer statistics, 2022
CA A Cancer Journal for Clinicians|2022
18.2k cit.

Reagents for Cancer Genomics and Diagnostics

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Takara Bio

ThruPLEX Plasma-seq Kit

Cited in 17 papers
#THRUPLEX-PLASMA
View Evidence →

⭐ Top Rated

Best all-around

Thermo Fisher ScientificEvidence 77

CD326 (EpCAM) Monoclonal Antibody (VU-1D9), Alexa Fluor Plus 647

Cited in 18 papers
#756-1062-94
View Evidence →
Thermo Fisher ScientificEvidence 66

EpCAM Monoclonal Antibody (VU-1D9), Alexa Fluor 647

Cited in 18 papers
#MA562295
View Evidence →
Thermo Fisher ScientificEvidence 66

EPCAM Recombinant Rabbit Monoclonal Antibody

Cited in 18 papers
#RAB02297
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (E10) Mouse Monoclonal Antibody (SignalFlex™ Alexa Fluor® 700 Conjugate)

Cited in 33 papers
#81468$486
View Evidence →
RocheEvidence 75

VENTANA® anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody

Cited in 27 papers
#760-5095 (also 08033706001)
View Evidence →
Thermo Fisher ScientificEvidence 77

Phospho-BRAF (Ser729) Polyclonal Antibody

Cited in 23 papers
#PA5-105501
View Evidence →